Morgan Stanley’s Crescent Capital BDC CCAP Stock Holding History
Bought
Maintained
Sold
Other funds holding CCAP
TCDRS
FNF
SLF
AM
RCM
CC
Morgan Stanley's CCAP Position: Q2 2026 in Review
Morgan Stanley reduced its Crescent Capital BDC (CCAP) stake by 1.6% in Q2 2026, selling an estimated $17.8K and leaving 89,677 shares worth $979K. The position accounts for ﹤0.01% of the portfolio, ranked #5212.
Morgan Stanley first reported a position in CCAP in Q1 2020 and has held it in 26 quarters since. The position peaked at $3.07M in Q2 2022. 85 funds tracked by Wall St. Rank hold CCAP as of Q2 2026.
- Morgan Stanley held 89,677 shares of Crescent Capital BDC worth $979K as of Q2 2026.
- Morgan Stanley sold 1,459 Crescent Capital BDC shares in Q2 2026, an estimated $17.8K.
- Crescent Capital BDC made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #5212 holding.
- Morgan Stanley first reported a position in Crescent Capital BDC in Q1 2020 and has held it in 26 quarters since.
- Morgan Stanley's Crescent Capital BDC position peaked at $3.07M in Q2 2022.
- 85 funds tracked by Wall St. Rank held Crescent Capital BDC as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.